Shares of Spectral Medical Inc. (TSE:EDT – Get Free Report) crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$1.33 and traded as high as C$1.36. Spectral Medical shares last traded at C$1.30, with a volume of 49,942 shares traded.
Spectral Medical Stock Performance
The stock’s fifty day simple moving average is C$1.33 and its two-hundred day simple moving average is C$1.33. The company has a market cap of C$375.88 million, a price-to-earnings ratio of -9.29 and a beta of 0.61. The company has a debt-to-equity ratio of 26.03, a quick ratio of 0.45 and a current ratio of 0.61.
Spectral Medical (TSE:EDT – Get Free Report) last issued its earnings results on Friday, November 7th. The company reported C($0.11) earnings per share for the quarter. The company had revenue of C$0.68 million during the quarter. Equities research analysts anticipate that Spectral Medical Inc. will post -0.05 EPS for the current year.
About Spectral Medical
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The segments of the group are Spectral Medical Inc, which is the key revenue-generating segment that manufactures and sells its EAA diagnostic and certain proprietary reagents; Dialco Medical Inc segment; and Corporate.
Read More
- Five stocks we like better than Spectral Medical
- NEW LAW: Congress Approves Setup For Digital Dollar?
- The day the gold market broke
- Your Bank Account Is No Longer Safe
- What a Former CIA Agent Knows About the Coming Collapse
- He just nailed another gold prediction …
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
